Drug companies planning to raise prices on cancer drugs and other life-saving treatments are justifying…
development
-
-
STOCK MARKET
Goodbye, quiet quitting. Workers want to take on more responsibility — and need greater engagement from their boss in 2023.
by userby userQuiet quitting became a catchphrase in 2022, if not necessarily a trend. But some workers…
-
AbbVie Inc. executives lowered their outlook for the quarter and year in a filing with…
-
STOCK MARKET
Opinion: Skilled workers needed to operate the next generation of advanced tools
by userby userThe U.S. Navy is beginning to build 12 top-of-the-line nuclear submarines, with the first one scheduled…
-
STOCK MARKET
Australia approves extradition of former U.S. pilot accused of training Chinese
by userby userSYDNEY — Australia’s government approved a U.S. request to extradite a former American pilot allegedly…
-
STOCK MARKET
The top 1% was the only group to see real wage gains from 2020 to 2021, report says
by userby userInequality in the U.S. deepened in 2021, with the country’s top 0.1% experiencing a 18.5%…
-
STOCK MARKET
Trulieve agrees to study potential allergic reactions to cannabis dust in the workplace
by userby userTrulieve Cannabis Corp. said Thursday it has agreed to issue a study by May 29…
-
Novartis AG said Monday that a trial to evaluate prostate-cancer drug Pluvicto met its primary…
-
STOCK MARKET
GSK Phase 3 trial for Jemperli endometrial cancer treatment met primary endpoint
by userby userGSK PLC said Friday that a Phase 3 trial for its Jemperli treatment for advanced…
-
STOCK MARKET
5 things to know about the new Alzheimer’s drug — including why it may be risky for people who take blood thinners
by userby userShares of Eisai and Biogen did not move dramatically after the drug companies reported the…